ganirelix [3610]



ganirelix


SMILES CCNC(=NCCCC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CCCCN=C(NCC)NCC)NC(=O)[C@@H](Cc1ccc(O)cc1)NC(=O)[C@@H](CO)NC(=O)[C@H](Cc1cccnc1)NC(=O)[C@H](Cc1ccc(Cl)cc1)NC(=O)C(Cc1ccc2ccccc2c1)NC(C)=O)C(=O)N1CCCC1C(=O)N[C@H](C)C(N)=O)NCC
InChIKey GJNXBNATEDXMAK-RXXWGPEVSA-N
Sequence AFASYXLXPA
HELM PEPTIDE1{[ac].[*C(=O)C(Cc1ccc2ccccc2c1)N* |$_R2;;;;;;;;;;;;;;;;_R1$|].[*C(=O)[C@H](Cc1ccc(cc1)Cl)N* |$_R2;;;;;;;;;;;;;_R1$|].[*C(=O)[C@H](Cc1cccnc1)N* |$_R2;;;;;;;;;;;;_R1$|].[dS].[dY].[*C(=O)[C@@H](CCCCN=C(NCC)NCC)N* |$_R2;;;;;;;;;;;;;;;;;_R1$|].L.[*C(=O)[C@H](CCCCN=C(NCC)NCC)N* |$_R2;;;;;;;;;;;;;;;;;_R1$|].(P,[dP]).[dA].[am]}$$$$V2.0

Chemical Properties

Hydrogen bond acceptors 16
Hydrogen bond donors 16
Rotatable bonds 44
Log P 2.273
Molecular weight (Da) 1568.8
Stereochemistry info unspecified


No bioactivity data available.

ganirelix


Drug properties

Molecular type Peptide
Physiological/Surrogate Surrogate
Approved drug No

Distribution across phases (no. indications)

Phase I 0
Phase II 0
Phase III 0
Phase IV 0

Database connections



Compound is not listed as a drug.